Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

The effect of adenovirus-mediated gene expression of FHIT in small cell lung cancer cells

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Biomarkers in Recurrent Grade III Glioma Patients Treated with Bevacizumab and Irinotecan

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Cell-free DNA in newly diagnosed patients with glioblastoma - a clinical prospective feasibility study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
The candidate tumor suppressor fragile histidine traid (FHIT) is frequently inactivated in small cell lung cancer (SCLC). Mutations in the p53 gene also occur in the majority of SCLC leading to the accumulation of the mutant protein. Here we evaluated the effect of FHIT gene therapy alone or in combination with the mutant p53-reactivating molecule, PRIMA-1(Met)/APR-246, in SCLC. Overexpression of FHIT by recombinant adenoviral vector (Ad-FHIT)-mediated gene transfer in SCLC cells inhibited their growth by inducing apoptosis and when combined with PRIMA-1(Met)/APR-246, a synergistic cell growth inhibition was achieved.
OriginalsprogEngelsk
TidsskriftCancer Investigation
Vol/bind29
Udgave nummer10
Sider (fra-til)683-91
Antal sider9
ISSN0735-7907
DOI
StatusUdgivet - 2011

ID: 33160438